The Food and Drug Administration has granted emergency authorization for the experimental antibody treatment given to President Trump shortly after he was diagnosed with Covid-19, giving doctors another option to treat Covid-19 patients as cases across the country continue to rise.
The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise in early studies at keeping the infection in check, reducing medical visits in patients who get the drug early in the course of their disease. A similar treatment, made by Eli Lilly, was given emergency approval earlier this month.
Women with high density breast tissue are least likely to have small tumors picked up by a standard mammogram.
The National Cancer Institute estimates that about 40% of women receiving mammograms have dense breasts, meaning that they have a high amount of connective and glandular tissue compared with less-dense breasts, which have a high amount of fatty tissue. Women with dense breasts have an increased risk of breast cancer, since dense breast tissue may hide smaller tumors normally picked up during mammograms, enabling the disease to advanced to a stage more difficult to treat.
To counteract this, the FDA has recently approved the first ultrasound device for use in combination with a standard mammogram on women with DBT who receive a negative mammogram (no disease found in your breasts) and no symptoms of breast cancer. Known as the somo-v Automated Breast Ultrasound System (ABUS) this specially-shaped transducer can automatically scan the entire breast in about one minute to produce several images for review using ultrasound capable of detecting small masses in dense breasts. Software analyzes the differences in how the sound waves are reflected off different tissues and back to the transducer to create an image a physician can review for abnormalities.
Ask your physician to recommend additional screening using ultrasound, if it has been determined you have dense breast tissue and you’ve received a negative mammogram.
We use cookies to improve your experience on our site. By agreeing to this, we can analyze browsing behavior and unique IDs on this site. Declining or revoking consent may affect certain features.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
